Unresectable Acral Lentiginous Melanoma
2 clinical trials · Condition
◉ Watch Unresectable Acral Lentiginous Melanoma
| Record | Firm | Date |
|---|---|---|
| Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial (NCT04462406) | ECOG-ACRIN Cancer Research Group | 2021-02-09 |
Track Unresectable Acral Lentiginous Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.